| 10010405 |
15-keto-17-phenyl trinor Prostaglandin F2α ethyl amide
|
|
- |
>98%
|
|
|
2008-01-10
|
174.757022899778
|
15-keto-17-phenyl-trinor-prostaglandin-f2-ethyl-amide
|
15-keto-Bimatoprost; 17-phenyl trinor PGF2α ethyl amide
|
17 phenyl trinor prostaglandins PGs ethyl amide intraocular hypotensive PGF2.alpha. IOP pressure glaucoma |
| 16816 |
15-keto Latanoprost
|
|
- |
>98%
|
|
|
|
296.190662983425
|
15-keto-latanoprost
|
|
eyes ophthalmology ophthalmological intraocular glaucoma esters FP receptors agonists IOP pressure prostaglandins hypotensive |
| 10010809 |
16-phenoxy tetranor Prostaglandin F2α cyclopropyl methyl amide
Exclusive |
|
- |
≥98%
|
|
✓ |
2009-10-12
|
0E-12
|
16-phenoxy-tetranor-prostaglandin-f2-cyclopropyl-methyl-amide
|
16-phenoxy tetranor PGF2α cyclopropyl methyl amide
|
FPs receptors PGF2α PGs intraocular pressure IOPs |
| 10010839 |
17-phenoxy trinor Prostaglandin F2α
|
|
- |
>98%
|
|
|
2008-02-04
|
302.605469613260
|
17-phenoxy-trinor-prostaglandin-f2
|
17-phenoxy trinor PGF2α
|
PGF2a PGF2.alpha. PGs analogs tetranors FPs receptors luteal IOP glaucoma |
| 10010723 |
17-phenoxy trinor Prostaglandin F2α isopropyl ester
Exclusive |
|
- |
≥98%
|
|
✓ |
2009-04-15
|
49.890953038674
|
17-phenoxy-trinor-prostaglandin-f2-isopropyl-ester
|
17-phenoxy-PGF2α isopropyl ester
|
FP receptors analogs intraocular pressure IOP FPs PGF2α |
| 16810 |
17-phenyl trinor Prostaglandin F2α
Exclusive |
|
38344-08-0 |
>98%
|
|
✓ |
|
223.522303867403
|
17-phenyl-trinor-prostaglandin-f2
|
17-phenyl trinor PGF2α; Bimatoprost (free acid)
|
analogs agonists FP receptors 17-phenyl-trinor-PGF2.alpha. 17-phenyl-trinor-PGF2alpha prostaglandins intraocular pressure iop |
| 10010605 |
17-phenyl trinor Prostaglandin F2α cyclopropyl amide
Exclusive |
|
- |
≥95%
|
|
✓ |
2009-05-08
|
195.191053973650
|
17-phenyl-trinor-prostaglandin-f2-cyclopropyl-amide
|
17-phenyl trinor PGF2α cyclopropyl amide; Bimatoprost cyclopropyl amide
|
PGF2α FP glaucoma ocular hypertension prostaglandins amides cycoprepylamides novel analogs |
| 516821 |
17-phenyl trinor Prostaglandin F2α EIA Kit
|
|
- |
|
|
|
|
98.330127071823
|
17-phenyl-trinor-prostaglandin-f2-eia-kit
|
17-phenyl trinor Prostaglandin F2α EIA Kit; Bimatoprost (fee acid) ELISA Kit
|
17-phenyl-trinor-PGF2alpha prostaglandins 17-phenyl-trinor-PGF2.alpha. measures kits eias enzyme immunoassays ELISAs EIA assays |
| 516821.1 |
17-phenyl trinor Prostaglandin F2α EIA Kit (Solid Plate)
|
|
- |
|
|
|
|
42.224475138121
|
17-phenyl-trinor-prostaglandin-f2-eia-kit-solid-plate
|
17-phenyl trinor Prostaglandin F2α ethyl amide EIA Kit (Solid Plate); Bimatoprost ELISA Kit (Solid Plate)
|
17-phenyl-trinor-PGF2alpha prostaglandins 17-phenyl-trinor-PGF2.alpha. measures kits EIAs enzyme immunoassays ELISAs assays |
| 10129 |
5-trans Latanoprost (free acid)
|
|
903549-49-5 |
>98%
|
|
|
2009-04-06
|
246.358250460405
|
5-trans-latanoprost-free-acid
|
|
isomers impurity intraocular pressure |
| 10008436 |
8-iso-17-phenyl trinor Prostaglandin F2β
|
|
- |
>98%
|
|
|
2006-06-14
|
92.983606945540
|
8-iso-17-phenyl-trinor-prostaglandin-f2
|
|
Bimatoprost analogs prostaglandins PGF2alpha PGF2.alpha. PGF2beta PGF2.beta. agonists 17-phenyl-trinor FP receptors inhibits inibitors inhibition isomers ophthalmology glaucoma IOP intraocular pressure ophthalmology |
| 13619 |
ACS 67
Exclusive |
|
1088434-86-9 |
≥95%
|
|
✓ |
2010-01-19
|
376.519337016574
|
acs-67
|
|
IOPs glaucoma intra ocular pressures latanoprost (free acid) hydrogen sulfide free acids H2Ss hypotensive carboxyl group reduced glutathione cGMP cyclic GMP |
| 10011546 |
AL 34662
|
|
210580-75-9 |
≥98%
|
|
|
2008-11-12
|
254.242209944751
|
al-34662
|
AL 34497
|
serotonins 5-HTs 5HT 5-hydroxy trptamine IOPs intraocular pressure glaucoma ophthalmology lower 5-hydroxytrptamine |
| 10010470 |
AL 8810 ethyl amide
|
|
- |
>98%
|
|
|
2008-01-18
|
10.236261510129
|
al-8810-ethyl-amide
|
|
FP receptors PGF2.alpha. prostamides ethanolamides IOP glaucoma contraction iris |
| 10008370 |
AL 8810 methyl ester
|
|
- |
>98%
|
|
|
2006-10-05
|
8.384723756906
|
al-8810-methyl-ester
|
|
FP antagonists prostaglandins PGFs receptors AL8810 AL-8810 PGF2alpha PGF2.alpha. analogs esters intraocular |
| 10007955 |
CAY10498
|
|
863202-33-9 |
>98%
|
|
|
2006-08-02
|
7.727734806630
|
cay10498
|
2-phenyl-amino-N6-endo-norbornyladenine
|
adenosine receptor antagonist A1 A2A A2B A3 AR G-protein stroke inflammation glaucoma neurodegenerative disease reversine dedifferentiation neurochemistry ophthalmology |
| 10008027 |
cGMP Bimatoprost
New GMP API |
|
155206-00-1 |
|
|
|
2010-08-20
|
0E-12
|
cgmp-bimatoprost
|
|
|
| 10011176 |
cGMP Latanoprost
New GMP API |
|
130209-82-4 |
|
|
|
2010-08-17
|
2631.591160220994
|
cgmp-latanoprost
|
|
|
| 30011 |
cGMP Travoprost
New GMP API |
|
157283-68-6 |
|
|
|
2010-08-17
|
607.734806629834
|
cgmp-travoprost
|
(+)-16-m-trifluoromethylphenoxy tetranor Prostaglandin F2α isopropyl ester; (+)-Fluprostenol ispopropyl ester
|
|
| 10349 |
Cytokeratin Monoclonal FITC Antibody (Clone C-11)
New |
|
- |
|
|
|
2010-04-14
|
14.650000000000
|
cytokeratin-monoclonal-fitc-antibody-clone-c-11
|
pan-Cytokeratin
|
cytokeratins pan-cytokeratins antibodies antiserum antisera isoforms western blots WB flow cytometry FC immunofluorescence IF immunoblotting proteins blotting |
| 10010978 |
Diphenylphosphine isopropyl ester
|
|
- |
>98%
|
|
|
2008-02-07
|
451.859429097605
|
diphenylphosphine-isopropyl-ester
|
DPP isopropyl ester
|
latanoprost glaucoma IOP intraocular pressure impurity commercial preparations |
| 16768 |
Fluprostenol
Exclusive |
|
54276-17-4 |
>95%
|
|
✓ |
|
11.800340699815
|
fluprostenol
|
16-m-trifluoromethylphenoxy tetranor PGF2α
|
16767 PGF2alpha PGF2.alpha. analogs FP agonists luteolysis prostaglandins receptors (+)-Fluprostenol |
| 516761 |
Fluprostenol EIA Kit
|
|
- |
|
|
|
|
36.966591160221
|
fluprostenol-eia-kit
|
16-m-trifluoromethylphenoxy tetranor Prostaglandin F2α; Fluprostenol ELISA Kit
|
prostaglandins measures kits eias enzyme immunoassays ELISAs eyes ophthalmology ophthalmological intraocular glaucoma esters assays (+)-Fluprostenols 16-meta-trifluoromethylphenoxy |
| 516761.1 |
Fluprostenol EIA Kit (Solid Plate)
|
|
- |
|
|
|
|
41.073990178023
|
fluprostenol-eia-kit-solid-plate
|
16-m-trifluoromethylphenoxy tetranor Prostaglandin F2α; Fluprostenol ELISA Kit (Solid Plate)
|
prostaglandins measures kits eias enzyme immunoassays ELISAs eyes ophthalmology ophthalmological intraocular glaucoma esters assays (+)-Fluprostenols 16-meta-trifluoromethylphenoxy |
| 10010406 |
Fluprostenol methyl amide
Exclusive |
|
- |
≥98%
|
|
✓ |
2009-04-17
|
7.098072437077
|
fluprostenol-methyl-amide
|
|
FPs PGF2α glaucoma ocular hypertension fluprostenol luteolysis |
| 10010151 |
Fluprostenol methyl ester
|
|
73275-76-0 |
≥98%
|
|
|
2009-03-16
|
6.269861878453
|
fluprostenol-methyl-ester
|
|
FP PGF2.alpha. glaucoma ocular hypertension fluprostenol luteolysis hair growth |
| 10004236 |
Fluprostenol serinol amide
|
|
- |
>98%
|
|
|
2004-09-23
|
56.417513812154
|
fluprostenol-serinol-amide
|
Flu-SA
|
PGF2.alpha. PGF2alpha analogs agonists prostaglandins receptors amides cannabinoids CB1 |
| 16812 |
Latanoprost
|
|
130209-82-4 |
>98%
|
|
|
|
1287.052980794527
|
latanoprost
|
CAY530500; 17-phenyl-13,14-dihydro trinor Prostaglandin F2α isopropyl ester; 17-phenyl-13,14-dihydro trinor PGF2α isopropyl ester
|
eyes ophthalmology ophthalmological intraocular glaucoma esters FP receptors agonists IOP pressure prostaglandins 17-phenyl-13,14-dihydro-trinor-PGF2.alpha. 17-phenyl-13,14-dihydro-trinor-PGF2alpha |
| 10006556 |
Latanoprost-d4
|
|
- |
≥99% deuterated product
|
|
|
2005-11-30
|
91.267286678943
|
latanoprost-d4
|
17-phenyl-13,14-dihydro trinor Prostaglandin F2α-d4 isopropyl ester
|
eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular acids GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 17-phenyl-13,14-dihydro-trinor-PGF2.alpha.-d4 17-phenyl-13,14-dihydro-trinor-PGF2alpha-d5 17-phenyl-13,14-dihydro trinor-PGF2a-d4 PGs |
| 516811 |
Latanoprost EIA Kit
|
|
- |
|
|
|
|
223.201397790055
|
latanoprost-eia-kit
|
Latanoprost ELISA Kit; PhXA 85 EIA Kit; 17-phenyl-13,14-dihydro trinor Prostaglandin F2α isopropyl ester EIA Kit; 17-phenyl-13,14-dihydro trinor Prostaglandin F2α EIA Kit
|
solid plates prostaglandins measures kits eias enzyme immunoassays ELISAs eyes ophthalmology ophthalmological intraocular glaucoma esters FP receptors agonists phxa85 17-phenyl-13,14-dihydro-trinor-PGF2alpha 17-phenyl-13,14-dihydro-trinor-PGF2.alpha. assays |
| 16811 |
Latanoprost (free acid)
|
|
41639-83-2 |
>98%
|
|
|
|
159.068947513812
|
latanoprost-free-acid
|
PhXA 85; Lat-FA; 17-phenyl-13,14-dihydro trinor Prostaglandin F2α; 17-phenyl-13,14-dihydro trinor PGF2α
|
eyes glaucoma prostaglandins agonists FP receptors phxa85 ophthalmology ophthalmological intraocular acids 17-phenyl-13,14-dihydro-trinor-PGF2.alpha. PhXA85 17-phenyl-13,14-dihydro-trinor-PGF2alpha IOP |
| 12990 |
Prostaglandin D3
|
|
71902-47-1 |
>98%
|
|
|
|
97.405607734806
|
prostaglandin-d3
|
PGD3
|
PGD3 omega-3 w-3 .omega.-3 metabolites EPA eicoaspentaenoic acid prostaglandins |
| 14990 |
Prostaglandin E3
|
|
802-31-3 |
>98%
|
|
|
|
9.519558011049
|
prostaglandin-e3
|
PGE3
|
PGE3 omega-3 metabolites prostaglandins .omega.-3 w-3 intraocular pressure IOP COX cyclooxygenaes eyes |
| 10005440 |
Tafluprost
|
|
209860-87-7 |
>98%
|
|
|
2004-10-05
|
470.103922651933
|
tafluprost
|
AFP-168
|
eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular acids 17-phenyl trinor-PGF2.alpha. 17-phenyl trinor-PGF2alpha 15-deoxy-15,15-difluoro PGF analogs 16-phenoxy hypotensive |
| 10005439 |
Tafluprost (free acid)
|
|
209860-88-8 |
>98%
|
|
|
2004-09-22
|
238.809290976059
|
tafluprost-free-acid
|
AFP-172
|
eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular AFP172 hypotensives pressure IOP |
| 10007207 |
tetranor-12(S)-HETE
|
|
121842-79-3 |
>98%
|
|
|
2005-12-07
|
35.527476979742
|
tetranor-12-s-hete
|
|
neuroscience peroxisomes metabolites arachidonic acids metabolisms 12-lipoxygenases 12-LOs platelets leukocytes smooth muscle cells tumors adhesion endothelial fibronectin subendothelial matrix b-oxidation .beta.-oxidation tissues Lewis lung carcinomas controlling inflammations inflammatory responses injured corneas Zellweger's syndromes peroxisomal abnormalities inability metabolizes symptoms diseases derivatives reasearch tools elucidations metabolic fate cancers ophthalmology |
| 10010421 |
Zaprinast
|
|
37762-06-4 |
≥98%
|
|
|
2008-09-18
|
9.154272559852
|
zaprinast
|
2-(o-Propoxyphenyl)-8-azapurin-6-one; M&B 22,948
|
sildenafil viagra phophodiesterase cGMP PDE5 GRP35 inhibitors inhibits inhibition M&B 22948 55122-20-8 |
| 10009992 |
Zeaxanthin
|
|
144-68-3 |
≥98%
|
|
|
2009-02-02
|
25.021215469614
|
zeaxanthin
|
Zeaxanthol; Xanthophyll 3; Anchovyxanthin
|
carotenoid degeneration AMDs luteins diabetes antioxidant oxidative injury injuries VEGFs macula |
| 16837 |
β-Carotene
New |
|
7235-40-7 |
≥95%
|
|
|
2010-08-20
|
0E-12
|
-carotene
|
Lucarotin; Provatene; Solatene; KPMK; Food Orange 5; Provitamin A; NSC 62794
|
vitamins A antioxidant retinol retinoic acids vision bone growth receptors RAR cell differentiation 116-32-5 31797-85-0 lucaratin lurotin provatenol serlabo βCarotene β Carotene b-carotene carotaben b bcarotene retinol |